Immune deficiency of the uremic patient.
Chatenoud
L
L
INSERM U25, CNRS UA122, Hôpital Necker, Paris, France.
Herbelin
A
A
Beaurain
G
G
Descamps-Latscha
B
B
D001402:B-Lymphocytes / Q000276:immunology; D001798:Blood Proteins / Q000032:analysis; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology* / Q000276:immunology; D007375:Interleukin-1 / Q000097:blood; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D010586:Phagocytes / Q000473:pathology; D015375:Receptors, Interleukin-2 / Q000032:analysis; D006435:Renal Dialysis / Q000009:adverse effects; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D014511:Uremia / Q000150:complications* / Q000276:immunology / Q000628:therapy
D001798:Blood Proteins; D007375:Interleukin-1; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha